ECG-I Targeted Ablation for Persistent AF Not Responding to Pulmonary Vein Isolation Results of a Two Staged Strategy.
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.
Also called NCT04633265
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT04633265
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT04633265. Allocation not applicable; no masking; primary purpose treatment. Start 2018-01-10 (actual); primary completion 2021-03-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ECG-I Targeted Ablation for Persistent AF Not Responding to Pulmonary Vein Isolation Results of a Two Staged Strategy.
- Acronym
- TARGET-AF2
- Condition
- Atrial Fibrillation
- Intervention (Device)
- ECG-I Mapping of Atrial Fibrillation
- Lead sponsor
- Barts & The London NHS Trust
Record details
- Record id
cardio:ct-nct04633265- Content hash
53bc8d5b4816d60533f2fef55c7505d89d07dbdf6da326af4702c756a18c81fe